Shanghai Haohai Biological Technology : REPLY SLIP FOR THE 2020 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON FRIDAY, FEBRUARY 14, 2020
December 30, 2019 at 09:16 am
Share
Shanghai Haohai Biological Technology Co., Ltd.*
上 海 昊 海 生 物 科 技 股 份 有 限 公 司
(a joint stock company incorporated in the People's Republic of China with limited liability)
(Stock Code: 6826)
REPLY SLIP FOR THE 2020 FIRST EXTRAORDINARY GENERAL MEETING
TO BE HELD ON FRIDAY, FEBRUARY 14, 2020
To: Shanghai Haohai Biological Technology Co., Ltd. (the "Company")
I/We(Note1)
of address:
and telephone number:
being the registered holder(s) of(Note 2) H
shares of RMB1.00 each in the share capital of the Company hereby inform the Company that I/we intend to attend or appoint a proxy(ies) to attend on my/our behalf the 2020 first extraordinary general meeting to be held at 2:00 p.m., on Friday, February 14, 2020 at Multi-function Hall, 5/F, Gubei Garden Hotel, No. 1446 Hongqiao Road, Changning District, Shanghai, PRC.
Dated this
day of
Signature(s):
Notes:
Please insert the full name(s) and address(es) of shareholder(s) as shown in the register of members in BLOCK CAPITALS.
Please insert the number of H shares of the Company registered in your name(s). If these are not completed, this reply slip will be deemed to relate to all number of H shares registered in your name(s).
Please complete and sign this reply slip and return it to the Company's H share registrar, Computershare Hong Kong Investor Services Limited (for H shareholders) on or before Friday, January 24, 2020 by hand, by post or by fax.
The address and contact details of the Company's H share registrar, Computershare Hong Kong Investor Services Limited is:
17M Floor, Hopewell Centre
183 Queen's Road East Wanchai, Hong Kong Telephone: (852) 2862 8555
Facsimile: (852) 2865 0990/(852) 2529 6087
* For identification purpose only
Attachments
Original document
Permalink
Disclaimer
Shanghai Haohai Biological Technology Co. Ltd. published this content on 30 December 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 30 December 2019 14:15:08 UTC
Shanghai Haohai Biological Technology Co., Ltd. is a China-based company principally engaged in biological technology-related businesses. The businesses of the Company include the manufacture and sales of biological and medical hyaluronate, the research and development of biological engineering and pharmaceutical products and the provision of related services. Its products include orthopedics products, medical aesthetics and wound care products, ophthalmology products and anti-adhesion and hemostasis products, among others. Orthopedics products include sodium hyaluronate injection, medical chitosan and medical sodium hyaluronate gel. Medical aesthetics and wound care products include recombinant human epidermal growth factor (rhEGF), among others. Ophthalmology products include ophthalmic viscoelastic devices and lubricant eye drops. Anti-adhesion and hemostasis products include medical collagen sponges, among others. The Company mainly operates businesses in Mainland China.